eddii is a health technology company that builds a virtual care platform focused on diabetes and endocrine condition management. Its core product is an engaging, gamified app that integrates daily health tracking with expert virtual endocrinology care, serving both children and adults. The platform connects patients with licensed endocrinologists for timely virtual visits, offers continuous glucose monitor (CGM) integration (notably with Dexcom devices), and includes features like quizzes, games, and mental health support to improve user engagement and health outcomes. eddii addresses the challenge of difficult access to endocrinologists and the complexity of diabetes self-management by making care more accessible, interactive, and comprehensive. The company has demonstrated growth momentum by expanding its services geographically and broadening its user base from pediatric to adult patients in multiple U.S. states[1][2][3].
eddii was founded in New York City as a response to the need for more accessible and engaging diabetes care. While specific founders’ names are not detailed in the sources, the company emerged with a focus on combining technology, virtual care, and behavioral engagement to improve diabetes management. Early traction came from its innovative approach of gamifying diabetes tracking and integrating virtual endocrinology visits, which helped differentiate it in a crowded digital health space. The expansion from pediatric care to adult care and the integration with popular CGM devices mark pivotal moments in its evolution[1][3].
eddii rides the growing trend of digital health and telemedicine, particularly in chronic disease management. The timing is favorable due to increasing demand for virtual care accelerated by healthcare access challenges and the rise of connected medical devices like CGMs. Market forces such as the need for scalable, patient-centered diabetes care and the integration of behavioral health into chronic disease management work in eddii’s favor. By combining clinical endocrinology with gamified digital engagement, eddii influences the broader ecosystem by demonstrating how technology can improve adherence, outcomes, and patient satisfaction in chronic disease management[2][3].
Looking ahead, eddii is poised to expand its geographic reach and deepen its integration with emerging diabetes technologies. Trends such as AI-driven personalized care, increased insurance coverage for virtual services, and growing patient demand for convenient, engaging health management tools will shape its trajectory. Its influence may evolve from a niche diabetes care platform to a broader endocrine and chronic condition management leader, potentially incorporating more advanced analytics and expanding partnerships with healthcare providers and payers. eddii’s innovative blend of clinical care and gamification positions it well to redefine patient engagement in chronic disease management[3][5].
eddii has raised $5.0M in total across 2 funding rounds.
eddii's investors include Flare Capital Partners, Kapor Capital, Seae Ventures.
eddii has raised $5.0M across 2 funding rounds. Most recently, it raised $2.0M Seed in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $2.0M Seed | Flare Capital Partners, Kapor Capital, Seae Ventures | |
| Jan 1, 2023 | $3.0M Seed | Flare Capital Partners, Kapor Capital, Seae Ventures |